Innovative biological products, empowering gene and cell therapy
GeneMedi is committed to providing high-quality biological reagents and solutions for innovative GCT pharmaceutical companies
Product Center
Providing comprehensive solutions for gene and cell therapy
AAV Solutions
Offering complete AAV workflow support from purification to titer detection, efficiently empowering gene therapy R&D.
Cell Therapy Products
High-quality flow cytometry antibodies, VHH detection antibodies, and cell sorting solutions to precisely support cell analysis.
Antibodies and ADC Products
Highly specific anti-Payload antibodies and advanced antibody engineering platforms to accelerate biologics development.
Technology Platform
An AI-driven innovative technology platform accelerating the drug development process
TAURUS™ + LIBRA™ Ligand Development
Integrating AI-assisted protein design and antibody development technologies to create ligands with high affinity and specificity, providing core technical support for purification resins.
AffProX™ Resin Development
In-house development, evaluation, and production system for affinity media (microspheres, nanobeads, etc.), ensuring comprehensive optimization of performance, production capacity, and continuous supply.
G-NEXT™ AAV Platform
Covers AAV virus production, purification, and process development, AAV capsid evolution, with extensive experience in large-scale production across multiple serotypes.
SOLIDCyte™ Cell Process
A platform for multi-immune cell separation, purification, amplification, functional characterization, and closed-loop process validation, ensuring process stability.
Core Advantages
Exceptional quality, professional services, empowering every research endeavor
International Quality System
Strict compliance with ISO 9001 & ISO 13485 standards, establishing a digital quality traceability system to ensure product excellence.
Professional Application Team
30+ interdisciplinary experts with an average of 10+ years of industry experience, deeply understanding GCT and antibody development needs.
Underlying Technological Innovation
AI-driven product design platform, combined with a million-level biological big database, accelerating product iteration and performance enhancement.
GeneMedi / YaoNuo Biotech
Innovative Bioproducts, Empowering Gene & Cell Therapy
Founded in 2018 by a team of interdisciplinary scientists with extensive experience in drug R&D, CMC process development, computational biology, and materials chemistry, GeneMedi / YaoNuo Biotech is dedicated to providing efficient purification and quality control solutions for gene and cell therapy (GCT) drug development.
